Ledger.Open graph →
SEC Form D · filed August 31, 2023

RVL Pharmaceuticals plc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BRIDGEWATER, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Alisa Lask · BRIDGEWATER, NJDirectorBrian Markison · ROCKVILLE, MDExec · DirectorGregory Cowan · BRIDGEWATER, NJDirectorJuan Vergez · BRIDGEWATER, NJDirectorJoaquin Benes · BRIDGEWATER, NJDirectorMichael Debiasi · BRIDGEWATER, NJDirectorJames Schaub · BRIDGEWATER, NJExecBrian Markison · ROCKVILLE, MDExec · DirectorGregory Cowan · BRIDGEWATER, NJDirectorJuan Vergez · BRIDGEWATER, NJDirectorJoaquin Benes · BRIDGEWATER, NJDirectorMichael Debiasi · BRIDGEWATER, NJDirectorAlisa Lask · BRIDGEWATER, NJDirectorJames Schaub · BRIDGEWATER, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗